## Investigation of Renal Drug Elimination ### Concept To determine whether a drug accumulates in renal impairment, we must quantify the **fraction of total body clearance that is attributable to the kidneys**. ### Why Renal Clearance (CLr) vs Total Clearance (CLtotal) is Correct **Key Point:** The ratio $\frac{CLr}{CLtotal}$ tells us what percentage of drug elimination is renal. If this ratio is high (>50%), the drug will accumulate significantly in renal failure and requires dose adjustment. **High-Yield:** - Renal clearance is determined by: $CLr = GFR \times f_u \times (1 + \frac{Secretion}{Filtration})$ - Where $f_u$ = fraction unbound to plasma proteins - Measurement requires collection of urine and plasma samples over a timed interval (typically 24 hours) to calculate: $CLr = \frac{Urine\ concentration \times Urine\ volume}{Plasma\ concentration \times Time}$ ### Clinical Application | Scenario | CLr/CLtotal | Action | |----------|-------------|--------| | <20% renal elimination | Low | No dose adjustment needed in renal failure | | 20–50% renal elimination | Moderate | Consider dose reduction in severe renal impairment | | >50% renal elimination | High | Significant dose reduction or interval extension required | **Clinical Pearl:** Drugs with high renal clearance (e.g., aminoglycosides, ACE inhibitors, digoxin) are notorious for accumulation in CKD and require careful monitoring or avoidance. ### Why This Matters in CKD In a patient with eGFR 25 mL/min/1.73m², the GFR is reduced to ~25% of normal. If the drug relies heavily on renal elimination, plasma concentrations will rise, increasing toxicity risk. Measuring CLr in this patient (or using published CLr data) allows calculation of adjusted clearance and safe dosing. [cite:KD Tripathi 8e Ch 5]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.